VolitionRx Limited said it will host a conference call on Friday, August 14, 2026 at 8:30 a.m. U.S. Eastern Time to discuss its financial and operating results for the second quarter of 2026 and provide a business update. Louise Batchelor, Group Chief Marketing & Communications Officer, will host the call alongside Cameron Reynolds, President and Group Chief Executive Officer, and Terig Hughes, Group Chief Financial Officer. The company said the call will cover key events during the second quarter, subsequent developments and upcoming milestones. A live audio webcast will be available, and a telephone replay will remain accessible until August 28, 2026. Volition describes itself as a multi-national company focused on epigenetics, developing blood tests aimed at earlier detection and monitoring of diseases including some cancers and conditions associated with NETosis such as sepsis.